Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
J Adv Pract Oncol
.
2015 Sep-Oct;6(5):420-31.
doi: 10.6004/jadpro.2015.6.5.3.
Epub 2015 Sep 1.
Authors
Gretchen Anne McNally
1
,
Jennifer M Long
1
,
Lynne R Brophy
1
,
Maria R Badillo
1
Affiliation
1
1The Ohio State University-Arthur G. James Cancer Hospital, Columbus, Ohio; 2Whittingham Cancer Center, Norwalk Hospital, Norwalk, Connecticut; 3TriHealth Cancer Institute, Cincinnati, Ohio; 4MD Anderson Cancer Center, Houston, Texas.
PMID:
27069735
PMCID:
PMC4803460
DOI:
10.6004/jadpro.2015.6.5.3
No abstract available
Publication types
Review